EBR Systems, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EBRCZ research report →
About the company
EBR Systems, Inc. focuses on developing internal medical devices that utilize wireless technology for tissue stimulation. A key offering is their WiSE cardiac resynchronization therapy (CRT) system, which leverages proprietary cable-free technology to deliver electrical pacing directly into the heart's left ventricle.
- CEO
- John Graham McCutcheon
- IPO
- 2023
- Employees
- 89
- HQ
- Sunnyvale, CA, US
Price Chart
- Market Cap
- $194.77M
- P/E
- -3.24
- P/S
- 34.25
- P/B
- 141.86
- EV/EBITDA
- -3.76
- Div Yield
- 0.00%
- Gross Margin
- 17.00%
- Op Margin
- -1322.69%
- Net Margin
- -1393.29%
- ROE
- -179.23%
- ROIC
- -75.41%
- Revenue
- $1.62M · 0.00%
- Net Income
- $-48,758,000 · -141.68%
- EPS
- $-0.12 · 0.00%
- Op Income
- $-47,690,606
- FCF YoY
- -37.04%
- 52W High
- $1.50
- 52W Low
- $0.19
- 50D MA
- $0.34
- 200D MA
- $0.60
- Beta
- 0.55
- Avg Volume
- 6.05K
Get TickerSpark's AI analysis on EBRCZ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our EBRCZ coverage
Recent articles, reports, and earnings notes.
No research on EBRCZ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EBRCZ report →Similar companies
Peers in the same neighborhood.